SCHEMBL8423787

SCHEMBL8423787

CCCNNC(=O)c1ccccc1

nearest known ligand 0.79

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 20/20 0.79
HDAC1 Q13547 16/20 0.79
HDAC2 Q92769 16/20 0.79
NCOR2 Q9Y618 6/20 0.79
HDAC8 Q9BY41 4/20 0.76
HDAC6 Q9UBN7 2/20 0.76
HDAC11 Q96DB2 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6636519 0.89 HDAC3 (0.82) HDAC3HDAC1HDAC2NCOR2HDAC8
SCHEMBL4415910 0.87 HDAC3 (0.76) HDAC3HDAC1HDAC2NCOR2HDAC8
SCHEMBL21435753 0.86 HDAC3 (1.00) HDAC3HDAC1HDAC2NCOR2HDAC8
SCHEMBL6640133 0.86 HDAC3 (0.77) HDAC3HDAC1HDAC2NCOR2HDAC8
SCHEMBL6637885 0.84 HDAC3 (0.73) HDAC3HDAC1HDAC2NCOR2HDAC8
SCHEMBL24051501 0.83 HDAC3 (0.72) HDAC3HDAC1HDAC2NCOR2HDAC8
SCHEMBL24051782 0.82 HDAC3 (0.68) HDAC3HDAC1HDAC2NCOR2HDAC8
SCHEMBL24051502 0.81 HDAC3 (0.70) HDAC3HDAC1HDAC2NCOR2HDAC8
SCHEMBL17141755 0.81 HDAC3 (1.00) HDAC3HDAC1HDAC2NCOR2HDAC8
SCHEMBL3001447 0.81 HDAC3 (0.81) HDAC3HDAC1HDAC2NCOR2HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113754591-B HDAC, JAK and BET three-target inhibitor and preparation method and application thereof 山东大学 2024-01-05 CN disclosed
CN-116867776-A Histone deacetylase inhibitor and application thereof 微境生物医药科技(上海)有限公司 2023-10-10 CN disclosed
CN-115073424-A Histone deacetylase inhibitor and application thereof 微境生物医药科技(上海)有限公司 2022-09-20 CN disclosed
US-5955506-A ACETAMIDOBENZAMIDE COMPOUNDS FOR TREATMENT OF PARKINSON'S DISEASE CENTAUR PHARMACEUTICALS, INC. (US) 1999-09-21 US disclosed